Skip to main content

Table 5 Univariate Analysis of Clinical, Pathologic and Treatment Variable for PFS in patients with osteosarcoma and high grade spindle cell sarcoma of bone

From: Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone

Characteristics Pts n. % 4-months PFS 95 % CI P-value
Overall
  46 46 31–61  
Age
 ≥18 years 23 65 43–88 0.4
 <18 years 23 35 17–53  
Sex
 Female 12 50 22–78 0.7
 Male 34 44 27–62  
Mets Site
 Lung only 24 61 41–81 0.1
 Multiple 22 30 11–50  
Line GD
 2 13 60 32–87 0.4
 ≥3 33 41 24.58  
ECOG
 0 29 54 35–72 0.003
 1 13 43 15–71  
 2 4 0 0  
Histology
 Osteosarcoma 35 56 39–73 0.005
 HGS 11 18 0–41  
  1. PFS Progression Free Survival, HGS high grade spindle cell sarcoma of bone, GD gemcitabine and docetaxel